Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI).
Lai
K K
KK
University of Massachusetts Medical Center, Worcester.
Gang
D L
DL
Zawacki
J K
JK
Cooley
T P
TP
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced; D016049:Didanosine / Q000009:adverse effects* / Q000627:therapeutic use; D005234:Fatty Liver / Q000139:chemically induced; D005878:Gilbert Disease / Q000150:complications; D006801:Humans; D008107:Liver Diseases / Q000201:enzymology / Q000473:pathology; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced; D000637:Transaminases / Q000097:blood
D000637:Transaminases; D016049:Didanosine